Valuation
- Market cap
- 631,000
- Revenue TTM
- $36,310,000
- Net income TTM
- $-5,980,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -16.47%
- Debt to equity
- 0.00
Trading
- Volume
- 113,900
- Avg volume
- 373,407
- Day's range
- $2.65 – $3.21
- Shares out
- 216,000
- Stochastic %K
- 15%
- Beta
- 1.20
- Analysts
- Sell
- Price target
- $56.00
Company profile
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, a...
Show more
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 954 330 0684
- Website
- https://sunshinebiopharma.com
- Address
- 333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States
Latest news
No headlines yet.